Glen MacDonald

Track

Insider profile

Currently holds a position at Carisma Therapeutics Inc

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 69% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Scientific Officer Carisma Therapeutics Inc Sept. 20, 2016 -
Glen MacDonald's trades of Carisma Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-06 2023-03-02
S Sale
50,863 +41.2%
279.62
US$1,968,140 		50,863 +41.2% 279.62 US$1,968,140
2023-03-06 2023-03-02
S Sale
91,561 -18.7%
351.26
US$2,003,860 		91,561 -18.7% 351.26 US$2,003,860
2023-03-06 2023-03-02
S Sale
72,459 +9.3%
484.56
US$2,008,306 		72,459 +9.3% 484.56 US$2,008,306
2023-02-23 2023-02-21
S Sale
25,927 -8.4%
0.59
US$15,227 		25,927 -8.4% 0.59 US$15,227